SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

9477	Companies
185475	Keywords
117817	Articles
99317	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 12/04/2025 at 11:05, 1 day 3 hours ago

Sanofi finalise l'acquisition de Vicebio

Acquisition De Sanofi Virus Respiratoires Vaccin Vicebio Pince Moléculaire Pipeline Des Vaccins
BRIEF

published on 12/04/2025 at 11:05, 1 day 3 hours ago

Sanofi Completes Acquisition of Vicebio

Respiratory Viruses Sanofi Acquisition Molecular Clamp Vicebio Vaccine Vaccine Pipeline
PRESS RELEASE

published on 12/04/2025 at 11:00, 1 day 3 hours ago

Communiqué de presse : Sanofi finalise l’acquisition de Vicebio
Sanofi finalise l’acquisition de Vicebio et renforce son pipeline de vaccins respiratoires avec un candidat-vaccin innovant contre le virus respiratoire syncytial (VRS) et le métapneumovirus humain (HMPV)

Acquisition Sanofi Vaccin Vicebio Respiratoire
PRESS RELEASE

published on 12/04/2025 at 11:00, 1 day 3 hours ago

Press Release: Sanofi completes acquisition of Vicebio
Sanofi completes acquisition of Vicebio, enhancing its vaccine portfolio with a combination vaccine candidate for RSV and HMPV. The 'Molecular Clamp' technology expands vaccine design capabilities

Acquisition Sanofi Vaccine Candidate RSV Vicebio
BRIEF

published on 11/25/2025 at 07:05, 10 days 7 hours ago

Dupixent : une avancée dans le traitement de l'urticaire chronique spontanée en Europe

Sanofi Dupixent Regeneron Traitement Innovant Urticaire Chronique
BRIEF

published on 11/25/2025 at 07:05, 10 days 7 hours ago

Dupixent: a breakthrough in the treatment of chronic spontaneous urticaria in Europe

Innovative Treatment Sanofi Dupixent Regeneron Chronic Urticaria
PRESS RELEASE

published on 11/25/2025 at 07:00, 10 days 7 hours ago

Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé comme étant le premier médicament ciblé dans l’UE depuis plus de dix ans contre l’urticaire chronique spontanée
Dupixent de Sanofi et Regeneron approuvé dans l'UE pour l'urticaire chronique spontanée. Impact positif sur les patients avec symptômes malgré antihistaminiques. Nouvelle option thérapeutique basée sur inhibition IL4 et IL13

Traitement Sanofi Dupixent Regeneron Urticaire
PRESS RELEASE

published on 11/25/2025 at 07:00, 10 days 7 hours ago

Press Release: Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Sanofi and Regeneron receive EU approval for Dupixent as targeted medicine for chronic spontaneous urticaria, significantly reducing itch and hives compared to placebo

Sanofi Dupixent EU Approval Regeneron Chronic Spontaneous Urticaria
PRESS RELEASE

published on 11/17/2025 at 18:15, 17 days 20 hours ago

Sanofi : Déclaration des transactions sur actions propres
PRESS RELEASE

published on 11/17/2025 at 18:15, 17 days 20 hours ago

Sanofi: Disclosure of trading in own shares

Accesswire

Published on 12/05/2025 at 14:00, 37 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 37 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 12 hours 2 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 12 hours 7 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 13 hours 37 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 14:22, 15 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 20 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 27 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 52 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 37 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting

Les Echos

Published on 12/05/2025 at 13:58, 39 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 5 hours 52 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 5 hours 52 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 5 hours 55 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 20 hours 23 minutes ago

Résiliation d'une convention conclue entre actionnaires

View all LES ECHOS COMFI WIRE